ADAP
Adaptimmune Therapeutics
ADAP
ADAP
41 hedge funds and large institutions have $181M invested in Adaptimmune Therapeutics in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $380M → $181M (-$198M)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.42M | |
| 2 | +$5.73M | |
| 3 | +$3.05M | |
| 4 |
Jennison Associates
New York
|
+$1.62M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$898K |
Top Sellers
| 1 | -$50.7M | |
| 2 | -$16.1M | |
| 3 | -$8.78M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.58M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$4.19M |